MM
ARKG icon

Main Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Main Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,137
Closed -$33K – 103
2025
Q4 		$33K Hold
1,137
– – ﹤0.01% 89
2025
Q3 		$32K Sell
1,137
-2,434
-68% -$61.5K ﹤0.01% 90
2025
Q2 		$87K Hold
3,571
– – 0.01% 72
2025
Q1 		$74K Sell
3,571
-1,244
-26% -$31.3K 0.01% 77
2024
Q4 		$113K Sell
4,815
-650,326
-99% -$16M 0.01% 72
2024
Q3 		$16.8M Sell
655,141
-26,330
-4% -$670K 1.38% 18
2024
Q2 		$16M Sell
681,471
-1,773
-0.3% -$44.7K 1.32% 23
2024
Q1 		$19.6M Buy
683,244
+1,775
+0.3% +$53.4K 1.68% 20
2023
Q4 		$22.4M Buy
681,469
+678,290
+21,337% +$18.4M 2.19% 16
2023
Q3 		$89K Hold
3,179
– – 0.01% 80
2023
Q2 		$108K Sell
3,179
-1,435
-31% -$45.1K 0.01% 81
2023
Q1 		$139K Buy
4,614
+980
+27% +$30.4K 0.01% 79
2022
Q4 		$103K Sell
3,634
-23,000
-86% -$730K 0.01% 96
2022
Q3 		$875K Buy
26,634
+2,641
+11% +$97K 0.11% 65
2022
Q2 		$756K Buy
23,993
+18,965
+377% +$663K 0.09% 67
2022
Q1 		$231K Sell
5,028
-12,696
-72% -$605K 0.02% 100
2021
Q4 		$1.08M Buy
17,724
+13,806
+352% +$954K 0.11% 65
2021
Q3 		$293K Sell
3,918
-7,057
-64% -$592K 0.03% 85
2021
Q2 		$1.01M Sell
10,975
-8
-0.1% -$680 0.11% 62
2021
Q1 		$975K Sell
10,983
-462
-4% -$45.8K 0.11% 62
2020
Q4 		$1.07M Buy
11,445
+10,213
+829% +$814K 0.14% 59
2020
Q3 		$78K Buy
1,232
+660
+115% +$38.7K 0.01% 104
2020
Q2 		$30K Buy
+572
New +$24.5K ﹤0.01% 100

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Main Management's ARKG Position: Q1 2026 in Review

Main Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 1,137 shares — an estimated $33K sold.

Main Management first reported a position in ARKG in Q2 2020 and held it in 23 quarters. The position peaked at $22.4M in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Main Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Main Management sold 1,137 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $33K.
  • Main Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 23 quarters.
  • Main Management's ARK Genomic Revolution ETF position peaked at $22.4M in Q4 2023.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Main Management's 13F filing for Q1 2026, filed 15 May 2026.